Self-assembled macromolecular nanocoatings to stabilize and control drug release from nanoparticles

Powder Technology

Volumn 256, Issue , 2014, Pages 470-476

  Strydom, Schalk J ^a,b   Otto, Daniel P ^b   Stieger, Nicole ^a,b   Aucamp, Marique E ^a,b   Liebenberg, Wilna ^b   De Villiers, Melgardt M ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b NORTH WEST UNIVERSITY   (South Africa)

Author keywords

Controlled release; Layer by layer; Nanoparticle; Poorly water soluble; Self assembly; Stability

Indexed keywords

AGGLOMERATION; CONVERGENCE OF NUMERICAL METHODS; DISSOLUTION; DRUG PRODUCTS; EMULSIFICATION; HYDROGELS; POLYELECTROLYTES; SELF ASSEMBLY; SUSPENSIONS (FLUIDS);

CONTROLLED DRUG RELEASE; CONTROLLED RELEASE; EMULSIFICATION METHODS; LAYER-BY-LAYERS; MANUFACTURING PROCESS; PARTICLE SIZE MEASUREMENT; POLYELECTROLYTE LAYERS; WATERSOLUBLE;

NANOPARTICLES;

CHITOSAN; CHONDROITIN SULFATE; CINEOLE; FUROSEMIDE; NANOCOATING; PACLITAXEL; RIFAMPICIN; TIOCARLIDE;

ARTICLE; BILAYER MEMBRANE; CHEMICAL PROCEDURES; CONFOCAL LASER MICROSCOPY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CRYSTALLIZATION; DRUG COATING; DRUG MANUFACTURE; DRUG SOLUBILITY; DRUG STABILITY; EMULSION; MACROMOLECULE; MICROSCOPY; PARTICLE SIZE; POWDER; QUARTZ CRYSTAL MICROBALANCE; SCANNING ELECTRON MICROSCOPY; SOLVENT EVAPORATION; SPECTROFLUOROMETRY; THICKNESS; ZETA POTENTIAL;

EID: 84896397695     PISSN: 00325910     EISSN: 1873328X     Source Type: Journal    
DOI: 10.1016/j.powtec.2014.01.088     Document Type: Article

References (28)

1. de Villiers M.M., van der Watt J.G. The measurement of mixture homogeneity and dissolution to predict the degree of drug agglomerate breakdown achieved through powder mixing. Pharm. Res. 1994, 11:1557-1561.
2. Wulff G. On the question of the rate of growth and dissolution of crystal surfaces. Z. Krist. Miner. 1901, 34:449-530.
3. Smolden V.F., Kildsig D.O. Vapor pressure of and solubility of small particles. Am. J. Pharm. Educ. 1967, 31:512-514.
4. Brayden D.J. Controlled release technologies for drug delivery. Drug Discov. Today 2003, 8:976-978.
5. Noyes A.A., Whitney W.R. The rate of solution of solid substances in their own solutions. J. Am. Chem. Soc. 1897, 19:930-934.
6. Tinke A.P., Vanhoutte K., de Maesschalck R., Verheyen S., de Winterm H.A. A new approach in the prediction of the dissolution behavior of suspended particles by means of their particle size distribution. J. Pharm. Biomed. Anal. 2005, 39:900-907.
7. Mosharraf M., Nyström C. Effect of particle size and shape on the surface specific dissolution rate of micronized practically insoluble drugs. Int. J. Pharm. 1995, 122:35-47.
8. Otto D.P., de Villiers M.M. Why is the nanosclae special (or not)? Fundamental properties and how it relates to the design of nano-enabled drug delivery systems. Nanotechnol. Rev. 2013, 2:171-199.
9. Devarakonda B., Judefeind A., Chigurupati S., Thomas S., Shah G.V., Otto D.P., de Villiers M.M. The effect of polyamidoamine (PAMAM) dendrimers on the in vitro cytotoxicity of paclitaxel in cultured prostate cancer (PC-3M) cells. J. Biomed. Nanotechnol. 2007, 3:384-393.
10. Devarakonda B., Otto D.P., Judefeind A., Hill R.A., de Villiers M.M. Effect of pH on the solubility and release of furosemide from polyamidoamine (PAMAM) dendrimer complexes. Int. J. Pharm. 2007, 345:142-153.
11. Devarakonda B., Hill R.A., de Villiers M.M. The effect of PAMAM dendrimer generation size and surface functional group on the aqueous solubility of nifedipine. Int. J. Pharm. 2004, 284:133-140.
12. Devarakonda B., Li N., de Villiers M.M. Effect of polyamidoamine (PAMAM) dendrimers on the in vitro release of water insoluble nifedipine from aqueous gels. AAPS PharmSciTech 2005, 6(3):E504-E512. Article 63.
13. Ibrahim H., Sallam E., Takkieddin M., Abu Shamat M. Dissolution characteristics of interactive powder mixtures. Part one: effect of solubility and particle size of excipients. Drug Dev. Ind. Pharm. 1988, 14:1249-1276.
14. Alonzo D.E., Gao Y., Zhou D., Mo H., Zhang G.G.Z., Taylor L.S. Dissolution and precipitation behaviour of amorphous solid dispersions. J. Pharm. Sci. 2011, 100:3316-3331.
15. Özkan Y., Doǧanay N., Dikmen N., Işmer A. Enhanced release of solid dispersions of etodolac in polyethylene glycol. Farmaco 2000, 55:433-438.
16. de Villiers M.M., Otto D.P., Strydom S.J., Lvov Y.M. Introduction to nanocoatings produced by layer-by-layer (LbL) self-assembly. Adv. Drug Deliv. Rev. 2011, 63:701-715.
17. Pargaonkar N., Lvov Y.M., Li N., Steenekamp J.H., de Villiers M.M. Controlled release of dexamethasone from microcapsules produced by polyelectrolyte layer-by-layer nanoassembly. Pharm. Res. 2005, 22:826-835.
18. Wu T., Sun Y., Li N., de Villiers M.M., Yu L. Inhibiting surface crystallization of amorphous indomethacin by nanocoating. Langmuir 2007, 23:5148-5153.
19. Ai H., Jones S.A., de Villiers M.M., Lvov Y.M. Nano-encapsulation of furosemide microcrystals for controlled drug release. J. Control. Release 2003, 86:59-68.
20. Li N., Kommireddy D.S., Lvov Y., Liebenberg W., Tiedt L.R., de Villiers M.M. Nanoparticle multilayers: surface modification of photosensitive drug microparticles for increased stability and in vitro bioavailability. J. Nanosci. Nanotechnol. 2006, 6:3252-3260.
21. Zahr A.S., de Villiers M.M., Pishko M.V. Encapsulation of drug nanoparticles in self-assembled macromolecular nanoshells. Langmuir 2005, 21:403-410.
22. Wan C.P., Park C.S., Kau B.H.S. A rapid and simple microfluorometric phagocytosis assay. J. Immunol. Methods 1993, 162:1-7.
23. Sahlin S., Hed J., Rundquist I. Differentiation between attached and ingested complexes by a fluorescence quenching cytofluorometric assay. J. Immunol. Methods 1983, 60:115-124.
24. Strydom S.J., Rose W.E., Otto D.P., Liebenberg W., de Villiers M.M. Poly(amidoamine) dendrimer-mediated synthesis and stabilization of silver sulfonamide nanoparticles with increased antibacterial activity. Nanomedicine 2013, 9:85-93.
25. Sauerbrey G. The use of quartz oscillators for weighing thin layers for microweighing. Z. Phys. 1959, 155:206-222.
26. Rasband W.S., Image J U.S. National Institutes of Health 2013, Bethesda, Maryland, USA, http://imagej.nih.gov/ij/.
27. United States Pharmacopeia USP 36-NF 31 2013, United States Pharmacopeial Convention, Rockville, MD, USA.
28. Li J., Bourne S.A., de Villiers M.M., Crider A.M., Caira M.R. Polymorphism of the antitubercular isoxyl. Cryst. Growth Des. 2011, 11:4950-4957.